Today: 11 Fevereiro 2026
Subscribe
Search result

Phantom 4 RTK/feed/category/dji-mavic-3-pl- Page 271

Texas Instruments (NASDAQ: TXN) Stock Surges on Dividend Hike, Then Plummets on Weak Outlook – Is a Slow Recovery Ahead?

Texas Instruments (NASDAQ: TXN) Stock Surges on Dividend Hike, Then Plummets on Weak Outlook – Is a Slow Recovery Ahead?

Texas Instruments reported Q3 2025 revenue of $4.74 billion, topping estimates, but issued weak Q4 guidance, sending shares down about 7% after hours. The company raised its quarterly dividend 4% to $1.42 per share, marking 22 consecutive annual increases. CEO Haviv Ilan will become chairman in 2026 as Rich Templeton retires. TI’s core markets remain sluggish despite strong demand for AI chips elsewhere in the sector.
22 Outubro 2025
·
NeurAxis (NRXS) Stock Skyrockets on First-Ever FDA Approval for GI Pain Device

NeurAxis (NRXS) Stock Skyrockets on First-Ever FDA Approval for GI Pain Device

NeurAxis announced FDA 510(k) clearance for its PENFS device to treat adult functional dyspepsia on Oct. 24, marking the first approved therapy for this condition. NRXS shares rose to $3.82 on Oct. 23 and traded higher pre-market after the news. The company recently raised $5 million and expanded insurance coverage to 53 million lives. Q2 revenue grew 46% year-over-year; analyst sentiment remains mixed.
24 Outubro 2025
·
Newegg Commerce (NEGG) Stock Rockets on AI & “Meme” Hype — 688% YTD Gains, CEO Upgraded to Board

Newegg Commerce (NEGG) Stock Rockets on AI & “Meme” Hype — 688% YTD Gains, CEO Upgraded to Board

Newegg shares jumped 40.8% to close at $66.72 on Oct 24, following a 7% gain the previous day and heavy trading volume. The stock is up roughly 500–600% over the past year, despite sharp volatility. In August, Newegg reported H1 2025 sales of $695.7 million, up 12.6% year-over-year, and turned profitable on an adjusted EBITDA basis. CEO Anthony Chow cited new GPU/CPU launches as key growth drivers.
25 Outubro 2025
·
Hidden ‘Planet-Killer’ Asteroid Found in Sun’s Glare Exposes Dangerous Blind Spot

Hidden ‘Planet-Killer’ Asteroid Found in Sun’s Glare Exposes Dangerous Blind Spot

Astronomers have discovered asteroid 2025 SC79, a 700-meter-wide object orbiting the sun every 128 days—second-fastest known—inside Venus’s orbit. The asteroid, hidden by the sun’s glare until twilight observations, poses no immediate threat to Earth, according to orbital data. Scientists warn similar objects are hard to detect. NASA plans to launch the NEO Surveyor telescope by 2027 to improve detection.
26 Outubro 2025
Opendoor’s Wild 2025 Ride: 1600% Meme Surge, New CEO & Crypto Pivot – What’s Next for OPEN Stock?

Opendoor’s Wild 2025 Ride: 1600% Meme Surge, New CEO & Crypto Pivot – What’s Next for OPEN Stock?

Opendoor shares closed at $7.97 on Oct. 24, up 13% after a cooler inflation report fueled hopes for Federal Reserve rate cuts. The stock remains up about 400% year-to-date despite cooling from a September peak of $10.87. Market cap stands near $5.9 billion. Morgan Stanley lifted its price target to $6 this week, but most analysts remain cautious.
26 Outubro 2025
··
GameStop’s Shocking 2025 Comeback: Crypto Bets, Trading Cards & Meme-Stock Mania Fuel GME Rally

GameStop’s Wild October: Pokémon Gambit, Meme Traders, and a New GME Stock Rally

GameStop shares traded at $23–$24 on October 27, 2025, flat after a 5% spike last week. The stock remains down about 25% year-to-date and near its lows. GameStop issued special warrants, completed an 11-for-10 stock split, and filed to raise capital, moves that triggered volatility. Q2 net income reached $168.6 million on $972.2 million revenue, with collectibles sales up 63% year-over-year.
27 Outubro 2025
Keurig Dr Pepper (KDP) Stock Soars on $18B Coffee Deal and Upgraded Forecast

Keurig Dr Pepper (KDP) Stock Soars on $18B Coffee Deal and Upgraded Forecast

Keurig Dr Pepper reported Q3 net sales of $4.31 billion, up 10.7% year-over-year, and announced an $18 billion takeover of JDE Peet’s. Management raised its 2025 net sales growth outlook and secured $7 billion in financing from Apollo and KKR. KDP shares jumped 5–6% in pre-market trading on Oct. 27 after the news. The stock remains near one-year lows but analysts see upside.
27 Outubro 2025
22nd Century Group (XXII) Soars After $9.5M Windfall, Expands Low-Nicotine Cigarette Rollout

22nd Century Group (XXII) Soars After $9.5M Windfall, Expands Low-Nicotine Cigarette Rollout

22nd Century Group shares surged over 39% in after-hours trading to about $2.10 after securing a $9.5 million insurance settlement. The company, now debt-free, recently expanded its FDA-authorized VLN low-nicotine cigarettes into 140 Circle K stores in Illinois and has sales authorized in 45 states. Despite these moves, 22nd Century remains unprofitable and will report Q3 results on November 4.
29 Outubro 2025
Ernexa Therapeutics (ERNA) Skyrockets on Cancer Therapy Deal – Will Rally Last?

Ernexa Therapeutics (ERNA) Skyrockets on Cancer Therapy Deal – Will Rally Last?

Ernexa Therapeutics shares jumped nearly 50% to $1.80 intraday on October 29, 2025, after announcing a manufacturing partnership with Cellipont Bioservices to advance its ovarian cancer cell therapy, ERNA-101, toward clinical trials. Trading volume surged. Despite the rally, ERNA stock remains down about 58% in 2025 and 89% year-on-year after previous setbacks and a reverse stock split.
29 Outubro 2025
·
Chipotle Stock Tumbles on Third Forecast Cut — Can the Burrito Chain Bounce Back?

Chipotle Stock Craters After Tepid Q3 Earnings – What’s Next for CMG?

Chipotle shares plunged 18% pre-market Oct. 30 after management cut its 2025 same-store sales forecast to a low-single-digit decline, citing persistent macroeconomic pressures. Q3 revenue rose 7.5% to $3.0 billion, but same-store sales grew just 0.3% as customer traffic fell for the third straight quarter. Chipotle opened 84 new restaurants and repurchased $686.5 million in stock. The stock is down 34% year-to-date.
30 Outubro 2025
··
Bristol Myers Squibb (NYSE:BMY) Surges on Q3 Earnings Beat and Raised Outlook – What’s Next for BMY Stock?

Bristol Myers Squibb (NYSE:BMY) Surges on Q3 Earnings Beat and Raised Outlook – What’s Next for BMY Stock?

Bristol Myers Squibb reported Q3 adjusted EPS of $1.63 on $12.2 billion revenue, beating estimates, and raised its 2025 outlook. Shares rebounded 3–4% after hitting a 52-week low, with dividend yield now near 5.5%. New drugs like Opdivo and Eliquis outperformed, offsetting a sharp Revlimid decline. The company acquired Orbital Therapeutics and launched schizophrenia drug Cobenfy, posting $62 million in early sales.
30 Outubro 2025
··
1 … 269 270 271 272 273 … 277
Go toTop